Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 171-176

  Katkin, Julie P ^a   Husser, Richard C ^a   Langston, Claire ^a   Welty, Stephen E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LUNG SURFACTANT;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUNG; NONHUMAN; RAT; TISSUE HOMOGENATE; TRANSGENE; VIRUS RECOMBINANT;

EID: 0031054120     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-171     Document Type: Article

References (20)

1. ANDERSON, W.F. (1992). Human gene therapy. Science 256, 808-813.
2. CANADA, A.T., HERMAN, L.A., and YOUNG, S.L. (1995). An age-related difference in hyperoxia lethality: role of lung antioxidant defense mechanisms. Am. J. Physiol.-Lung Cell. Mol. Physiol. 12, L539-L545.
3. CORCORAN, J.D., BERGGREN, P., SUN, B., HALLIDAY, H.L., ROBERTSON, B., and CURSTEDT, T. (1994). Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. Arch. Dis. Childhood 71, F165-F169.
4. EGBERTS, J., and DEWINTER, J.P. (1994). Meta-analyses of surfactant and bronchopulmonary dysplasia revisited. Lancet 344, 882.
5. ENGELHARDT, J.F., LITZKY, L., and WILSON, J.M. (1994). Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5, 1217-1229.
6. FLOTTE, T.R. (1993). Prospects for virus-based gene therapy for cystic fibrosis. J. Bioenerg. Biomemb. 25, 37-42.
7. FRANK, L. (1992). Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin. Perinatol. 19, 541-562.
8. GRAHAM, F.L. (1992). Adenovirus-based expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems. R.W. Ellis, ed. (Butterworth-Heinemann, Boston) pp. 363-390.
9. GRAHAM, F.L., and PREVEC, L. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Viral. 36, 59-72.
10. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Methods in Molecular Biology. E.J. Murray, ed. (The Humana Press, Inc., Clifton, NJ) pp. 109.
11. HUDAK, B.B., and EGAN, E.A. (1992). Impact of lung surfactant therapy on chronic lung diseases in premature infants. Clin. Perinatol. 19, 591-602.
12. JOBE, A.H. (1993). Pulmonary surfactant therapy. N. Engl. J. Med. 328, 861-868.
13. KATKIN, J.P., GILBERT, B.E., LANGSTON, C., FRENCH, K., and BEAUDET, A.L. (1995). Aerosol delivery of a β-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene Ther. 6, 985-995.
14. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
15. MORSY, M.A., ALFORD, E.L., BETT, A., GRAHAM, F.L., and CASKEY, C.T. (1993). Efficient adenoviral vector mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92, 1580-1586.
16. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
17. PALTA, M., WEINSTEIN, M.R., MCGUINNESS, G., GABBERT, D., BRADY, W., and PETERS, M.E. (1994). A population study: mortality and morbidity after availability of surfactant therapy. Arch. Pediatr. Adolesc. Med. 148, 1295-1301.
18. ROJAS, M.A., GONZALEZ, A., BANCALARI, E., CLAURE, N., POOLE, C., and SILVANETO, G. (1995). Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J. Pediatr. 126, 605-610.
19. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C. YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
20. ZAR, J.H. (1984). Biostatistical Analysis. (Prentice Hall, Englewood Cliffs, NJ) pp. 162-163.